J&J’s multiple myeloma drug reduces risk of death in late-stage study
Johnson & Johnson’s blockbuster blood cancer drug Darzalex significantly reduced the risk of disease progression or death in patients who have not been previously treated for multiple myeloma, late-stage study…
Evidence thin on medical pot, EU illegal drugs body says
By Axel Bugge LISBON: Evidence is still thin on the benefits of medicinal use of cannabis, an EU agency that monitors illegal drugs and addiction said on Tuesday, urging more…
JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial
Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved survival in blood cancer patients, compared with drugs currently used as the standard…
Drugmaker UCB backs Brexit Britain with $1.3 bln investment
Belgian drugmaker UCB expects to invest about 1 billion pounds ($1.3 billion) in Britain over the next five years, throwing its support behind the country’s life sciences sector despite Brexit…
RedHill Biopharma’s antibiotic succeeds in late-stage study
Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that…
Drug License Holders Raise Alarm On False Claims Of 100% Result Through Malaria Antibody IVD Kits
Drug license holders have urged the central and state drug regulators to scrutinise the claims made by manufacturers of malaria antibody IVD kits or malaria rapid diagnostic tests (RDTs) of…
Sun Pharma tumbles after report of probe
– Shares of India’s Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe against the country’s biggest drug manufacturer by market value.…
Drug buyers’ clubs aim to tackle HIV prevention ‘crisis’
By Sonia Elks LONDON: A new generation of drug buyers’ clubs like those set up at the height of the AIDS epidemic is seeking to combat a “crisis” in preventing…
Maha FDA Files FIRs. Against 11 Persons For Trading Immunoglobulin Injections In Open Market
The Maharshtra Food and Drug Administration (FDA) has filed FIRs. against 11 accused persons in a racket of trading immunoglobulin injections in the open market at prices as high as…
Govt Set To Dilute MD Rules For Testing Labs
New Delhi :The Central government is preparing to water down the regulatory requirements for medical device testing laboratories by providing exemption from mandatory National Accreditation Body for Testing and Calibration…
